Mixed invasive fungal infection due to Rhizomucor pusillus and Aspergillus niger in an immunocompetent patient;Infección fúngica invasiva mixta por Rhizomucor pusillus y Aspergillus niger en un paciente inmunocompetente

Revista Iberoamericana de Micologia

Volumn 32, Issue 1, 2015, Pages 46-50

  Pozo Laderas, Juan Carlos ^a   Pontes Moreno, Antonio ^a   Robles Arista, Juan Carlos ^a   Bautista Rodriguez, M Dolores ^a   Candau Alvarez, Alberto ^a   Caro Cuenca, Maria Teresa ^a   Linares Sicilia, María José ^a  

^a HOSPITAL UNIVERSITARIO REINA SOFÍA   (Spain)

Author keywords

Disseminated mucormycosis; Immunocompetent; Liposomal amphotericin B; Mixed invasive fungal infection; Pulmonary aspergillosis; Rhizomucor pusillus

Indexed keywords

AMPHOTERICIN B LIPID COMPLEX; AMPHOTERICIN B; ANTIFUNGAL AGENT; ANTIINFECTIVE AGENT;

ADOLESCENT; ARTICLE; ASPERGILLUS NIGER; CASE REPORT; COMPLICATION; DISEASE COURSE; EARLY DIAGNOSIS; ERADICATION THERAPY; HISTOPATHOLOGY; HOSPITAL ADMISSION; HOSPITAL DISCHARGE; HUMAN; IMMUNOCOMPETENCE; INFECTION CONTROL; LUNG ASPERGILLOSIS; MALE; MICROBIOLOGICAL EXAMINATION; MIXED INFECTION; MUCORMYCOSIS; PATHOGENESIS; PROGNOSIS; RHIZOMUCOR PUSILLUS; SEIZURE; SURGICAL TECHNIQUE; SURVIVAL RATE; TRAFFIC ACCIDENT; TREATMENT DURATION; AKINETIC MUTISM; ASPERGILLOSIS; COINFECTION; CRANIOCEREBRAL TRAUMA; GASTROINTESTINAL DISEASES; INTENSIVE CARE; ISOLATION AND PURIFICATION; LUNG DISEASES, FUNGAL; MICROBIOLOGY; MULTIMODALITY CANCER THERAPY; POSTOPERATIVE COMPLICATION; PROCEDURES; RHIZOMUCOR; SKULL FRACTURES; ULCER; WOUND INFECTION;

ASPERGILLUS NIGER; RHIZOMUCOR PUSILLUS;

ACCIDENTS, TRAFFIC; ADOLESCENT; AKINETIC MUTISM; AMPHOTERICIN B; ANTI-BACTERIAL AGENTS; ANTIFUNGAL AGENTS; ASPERGILLOSIS; ASPERGILLUS NIGER; COINFECTION; COMBINED MODALITY THERAPY; CRANIOCEREBRAL TRAUMA; GASTROINTESTINAL DISEASES; HUMANS; IMMUNOCOMPETENCE; INTENSIVE CARE; LUNG DISEASES, FUNGAL; MALE; MUCORMYCOSIS; POSTOPERATIVE COMPLICATIONS; RHIZOMUCOR; SKULL FRACTURES; ULCER; WOUND INFECTION;

EID: 84921879168     PISSN: 11301406     EISSN: 21739188     Source Type: Journal    
DOI: 10.1016/j.riam.2013.03.002     Document Type: Article

References (31)

1. Adam R.D., Hunter G., DiTomasso J., Comerci G. Mucormycosis: Emerging prominence of cutaneous infections. Clin Infect Dis 1994, 19:67-76.
2. Alfano C., Chiummariello S., Dessy L.A., Bistoni G., Scuderi N. Combined mucormycosis and aspergillosis of the rhinocerebral region. In Vivo 2006, 20:311-315.
3. Ayala-Gaytán J.J., Petersen-Morfín S., Guajardo-Lara C.E., Barbosa-Quintana A., Morfín-Otero R., Rodriguez-Noriega E. Cutaneous zygomycosis in immunocompetent patients in Mexico. Mycoses 2010, 53:538-540.
4. Benbow E.W., Stoddart R.W. Systemic zygomycosis. Postgrad Med J 1986, 62:985-996.
5. Bitar D., van Cauteren D., Lanternier F., Dannaoui E., Che D., Dromer F., et al. Increasing incidence of zygomycosis (mucormycosis), France, 1997-2006. Emerg Infect Dis 2009, 15:1395-1401.
6. Blin N., Morineau N., Gaillard F., Morin O., Milpied N., Harousseau J.L., et al. Disseminated mucormycosis associated with invasive pulmonary aspergillosis in a patient treated for post-transplant high-grade non-Hodgkin's lymphoma. Leuk Lymphoma 2004, 45:2161-2163.
7. Boelaert J.R., Vergauwe P.L., Vandepitte J.M. Mucormycosis infection in dialysis patients. Ann Intern Med 1987, 107:782-783.
8. Borrás R., Roselló P., Chilet M., Bravo D., de Lomas J.G., Navarro D. Positive result of the Aspergillus galactomannan antigen assay using bronchoalveolar lavage fluid from a patient with an invasive infection due to Lichtheimia ramosa. J Clin Microbiol 2010, 48:3035-3036.
9. Cuenca-Estrella M. Diagnóstico de laboratorio de la enfermedad fúngica invasora. Enferm Infecc Microbiol Clin 2012, 30:257-264.
10. De Pauw B., Walsh T.J., Donnelly J.P., Stevens D.A., Edwards J.E., Calandra T., et al. Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group. Clin Infect Dis 2008, 46:1813-1821.
11. Deja M., Wolf S., Weber-Carstens S., Lehmann T.N., Adler A., Ruhnke M., et al. Gastrointestinal zygomycosis caused by Mucor indicus in a patient with acute traumatic brain injury. Med Mycol 2006, 44:683-687.
12. Georgiadou S.P., Sipsas N.V., Marom E.M., Kontoyiannis D.P. The diagnostic value of halo and reversed halo signs for invasive mold infections in compromised hosts. Clin Infect Dis 2011, 52:1144-1155.
13. Gomes M.Z., Lewis R.E., Kontoyiannis D.P. Mucormycosis caused by unusual mucormycetes, non-Rhizopus, -Mucor, and -Lichtheimia species. Clin Microbiol Rev 2011, 24:411-445.
14. Goodill J.J., Abuelo J.G. Mucormycosis--a new risk of deferoxamine therapy in dialysis patients with aluminum or iron overload?. N Engl J Med 1987, 317:54.
15. Hamilos G., Samonis G., Kontoyiannis D.P. Pulmonary mucormycosis. Semin Respir Crit Care Med 2011, 32:693-702.
16. Ibrahim A.S., Spellberg B., Edwards J. Iron acquisition: A novel perspective on mucormycosis pathogenesis and treatment. Curr Opin Infect Dis 2008, 21:620-625.
17. Lanternier F., Dannaoui E., Morizot G., Elie C., Garcia-Hermoso D., Huerre M., et al. A global analysis of mucormycosis in France: the RetroZygo Study. Clin Infect Dis. 2005-2007, 2012(Suppl 1). S35- 43.
18. Lipový B., Rihová H., Hanslianová M., Kocmanová I., Zaloudíková Z., Kaloudová Y., et al. Unsuccessful therapy of combined mycotic infection in a severely burned patient: A case study. Acta Chir Plast 2009, 51:83-84.
19. Mayayo E., Stchigel A.M., Cano J.F., Bernal-Escoté X., Guarro J. Fascitis necrotizante por Saksenaea vasiformis en una paciente inmunocompetente tras un accidente de tráfico. Rev Iberoam Micol 2013, 30:57-60.
20. Petrikkos G., Skiada A., Lortholary O., Roilides E., Walsh T.J., Kontoyiannis D.P. Epidemiology and clinical manifestations of mucormycosis. Clin Infect Dis 2012, 54(Suppl 1):S23-S34.
21. Prabhu R.M., Patel R. Mucormycosis and entomophthoramycosis: A review of the clinical manifestations, diagnosis and treatment. Clin Microbiol Infect 2004, 10(Suppl 1):31-47.
22. Radowsky J.S., Strawn A.A., Sherwood J., Braden A., Liston W. Invasive mucormycosis and aspergillosis in a healthy 22-year-old battle casualty: Case report. Surg Infect (Larchmt) 2011, 12:397-400.
23. Ribes J.A., Vanover-Sams C.L., Baker D.J. Zygomycetes in human disease. Clin Microbiol Rev 2000, 13:236-301.
24. Roden M.M., Zaoutis T.E., Buchanan W.L., Knudsen T.A., Sarkisova T.A., Schaufele R.L., et al. Epidemiology and outcome of zygomycosis: A review of 929 reported cases. Clin Infect Dis 2005, 41:634-653.
25. Solano T., Atkins B., Tambosis E., Mann S., Gottlieb T. Disseminated mucormycosis due to Saksenaea vasiformis in an immunocompetent adult. Clin Infect Dis 2000, 30:942-943.
26. Spellberg B., Edwards J., Ibrahim A. Novel perspectives on mucormycosis: Pathophysiology, presentation, and management. Clin Microbiol Rev 2005, 18:556-569.
27. Spellberg B., Walsh T.J., Kontoyiannis D.P., Edwards J., Ibrahim A.S. Recent advances in the management of mucormycosis: From bench to bedside. Clin Infect Dis 2009, 48:1743-1751.
28. Torres-Narbona M., Guinea J., Muñoz P., Bouza E. Zigomicetos y zigomicosis en la era de las nuevas terapias antifúngicas. Rev Esp Quimioter 2007, 20:375-386.
29. Van Dam A.P., Pruijm M.T., Harinck B.I., Gelinck L.B., Kuijper E.J. Pneumonia involving Aspergillus and Rhizopus spp. after a near-drowning incident with subsequent Nocardia cyriacigeorgici and N. farcinica coinfection as a late complication. Eur J Clin Microbiol Infect Dis 2005, 24:61-64.
30. Van Sickels N., Hoffman J., Stuke L., Kempe K. Survival of a patient with trauma-induced mucormycosis using an aggressive surgical and medical approach. J Trauma 2011, 70:507-509.
31. Wahba H., Truong M.T., Lei X., Kontoyiannis D.P., Marom E.M. Reversed halo sign in invasive pulmonary fungal infections. Clin Infect Dis 2008, 46:1733-1737.